A citation-based method for searching scientific literature

Grzegorz Wiera, Jerzy W Mozrzymas. Cells 2021
Times Cited: 8







List of co-cited articles
22 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


MMPs in learning and memory and neuropsychiatric disorders.
Anna Beroun, Shiladitya Mitra, Piotr Michaluk, Barbara Pijet, Marzena Stefaniuk, Leszek Kaczmarek. Cell Mol Life Sci 2019
73
62

Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory.
Vanja Nagy, Ozlem Bozdagi, Anna Matynia, Marcin Balcerzyk, Pawel Okulski, Joanna Dzwonek, Rui M Costa, Alcino J Silva, Leszek Kaczmarek, George W Huntley. J Neurosci 2006
362
37

Altered Serum Levels of Matrix Metalloproteinase-2, -9 in Response to Electroconvulsive Therapy for Mood Disorders.
Chiyo Shibasaki, Minoru Takebayashi, Kei Itagaki, Hiromi Abe, Naoto Kajitani, Mami Okada-Tsuchioka, Shigeto Yamawaki. Int J Neuropsychopharmacol 2016
24
25

Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections.
Enrico Domenici, David R Willé, Federica Tozzi, Inga Prokopenko, Sam Miller, Astrid McKeown, Claire Brittain, Dan Rujescu, Ina Giegling, Christoph W Turck,[...]. PLoS One 2010
252
25



Synaptic Remodeling Depends on Signaling between Serotonin Receptors and the Extracellular Matrix.
Monika Bijata, Josephine Labus, Daria Guseva, Michał Stawarski, Malte Butzlaff, Joanna Dzwonek, Jenny Schneeberg, Katrin Böhm, Piotr Michaluk, Dmitri A Rusakov,[...]. Cell Rep 2017
72
25


Stress-related modulation of matrix metalloproteinase expression.
Eric V Yang, Cynthia M Bane, Robert C MacCallum, Janice K Kiecolt-Glaser, William B Malarkey, Ronald Glaser. J Neuroimmunol 2002
78
25

MMP-9 in translation: from molecule to brain physiology, pathology, and therapy.
Behnam Vafadari, Ahmad Salamian, Leszek Kaczmarek. J Neurochem 2016
183
25

Hippocampal extracellular matrix alterations contribute to cognitive impairment associated with a chronic depressive-like state in rats.
Danai Riga, Ioannis Kramvis, Maija K Koskinen, Pieter van Bokhoven, Johanneke E van der Harst, Tim S Heistek, A Jaap Timmerman, Pim van Nierop, Roel C van der Schors, Anton W Pieneman,[...]. Sci Transl Med 2017
55
25

Influence of matrix metalloproteinase MMP-9 on dendritic spine morphology.
Piotr Michaluk, Marcin Wawrzyniak, Przemyslaw Alot, Marcin Szczot, Paulina Wyrembek, Katarzyna Mercik, Nikolay Medvedev, Ewa Wilczek, Mathias De Roo, Werner Zuschratter,[...]. J Cell Sci 2011
163
25

Neural ECM proteases in learning and synaptic plasticity.
Effie Tsilibary, Athina Tzinia, Lidija Radenovic, Vera Stamenkovic, Tomasz Lebitko, Mariusz Mucha, Robert Pawlak, Renato Frischknecht, Leszek Kaczmarek. Prog Brain Res 2014
53
25



TIMP-1 abolishes MMP-9-dependent long-lasting long-term potentiation in the prefrontal cortex.
Pawel Okulski, Therese M Jay, Jacek Jaworski, Kamila Duniec, Joanna Dzwonek, Filip A Konopacki, Grzegorz M Wilczynski, Amelia Sánchez-Capelo, Jacques Mallet, Leszek Kaczmarek. Biol Psychiatry 2007
121
25

Extracellular proteolysis by matrix metalloproteinase-9 drives dendritic spine enlargement and long-term potentiation coordinately.
Xiao-bin Wang, Ozlem Bozdagi, Jessica S Nikitczuk, Zu Wei Zhai, Qiang Zhou, George W Huntley. Proc Natl Acad Sci U S A 2008
249
25




In vivo roles for matrix metalloproteinase-9 in mature hippocampal synaptic physiology and plasticity.
Ozlem Bozdagi, Vanja Nagy, Kimberly T Kwei, George W Huntley. J Neurophysiol 2007
136
25

Diffusion in brain extracellular space.
Eva Syková, Charles Nicholson. Physiol Rev 2008
789
25

Sex differences in the risk of schizophrenia: evidence from meta-analysis.
Andre Aleman, René S Kahn, Jean-Paul Selten. Arch Gen Psychiatry 2003
481
12

Possible Association between Serum Matrix Metalloproteinase-9 (MMP-9) Levels and Relapse in Depressed Patients following Electroconvulsive Therapy (ECT).
Chiyo Shibasaki, Kei Itagaki, Hiromi Abe, Naoto Kajitani, Mami Okada-Tsuchioka, Minoru Takebayashi. Int J Neuropsychopharmacol 2018
10
12

Epidemiology of schizophrenia: review of findings and myths.
Erick L Messias, Chuan-Yu Chen, William W Eaton. Psychiatr Clin North Am 2007
156
12

Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics.
Chi-Yu Lai, Elizabeth Scarr, Madhara Udawela, Ian Everall, Wei J Chen, Brian Dean. World J Psychiatry 2016
83
12

Relationship between matrix metalloproteinase-9 and oxidative stress in drug-free male schizophrenia: a case control study.
Sivasankar Devanarayanan, Hanumanthappa Nandeesha, Shivanand Kattimani, Siddharth Sarkar. Clin Chem Lab Med 2016
26
12

An Update on Promising Biomarkers in Schizophrenia.
David R Goldsmith, Courtney L Crooks, Elaine F Walker, Robert O Cotes. Focus (Am Psychiatr Publ) 2018
11
12

Plasma levels of matrix metalloproteinase-9 (MMP-9) are associated with cognitive performance in patients with schizophrenia.
Noriko Kudo, Hidenaga Yamamori, Tamaki Ishima, Kiyotaka Nemoto, Yuka Yasuda, Michiko Fujimoto, Hirotsugu Azechi, Tomihisa Niitsu, Shusuke Numata, Manabu Ikeda,[...]. Neuropsychopharmacol Rep 2020
6
16

Cytokine Alterations in Schizophrenia: An Updated Review.
Sara Momtazmanesh, Ameneh Zare-Shahabadi, Nima Rezaei. Front Psychiatry 2019
101
12

Quality of Life in Schizophrenia: What is Important for Persons with Schizophrenia in India?
Sumit Durgoji, Krishna Prasad Muliyala, Deepak Jayarajan, Santosh Kumar Chaturvedi. Indian J Psychol Med 2019
4
25

Assessment of cognitive insight: a qualitative review.
Sally E Riggs, Paul M Grant, Dimitri Perivoliotis, Aaron T Beck. Schizophr Bull 2012
104
12

Insight and gender in schizophrenia and other psychoses.
Jesus Cobo, Lourdes Nieto, Susana Ochoa, Esther Pousa, Judith Usall, Iris Baños, Beatriz González, Isabel Ruiz, Ada I Ruiz. Psychiatry Res 2016
18
12


Matrix metalloproteinase-9 increases the risk of cognitive impairment in schizophrenia.
Neha Keshri, Hanumanthappa Nandeesha, Medha Rajappa, Vikas Menon. Nord J Psychiatry 2021
5
20

Expression of anti-cardiolipin antibodies and inflammatory associated factors in patients with schizophrenia.
Sheng-Huang Chang, Szu-Yi Chiang, Chun-Ching Chiu, Chun-Chou Tsai, Huei-Huang Tsai, Chih-Yang Huang, Tsai-Ching Hsu, Bor-Show Tzang. Psychiatry Res 2011
52
12

DNA Methylation and Gene Expression of Matrix Metalloproteinase 9 Gene in Deficit and Non-deficit Schizophrenia.
Ju Gao, Hongwei Yi, Xiaowei Tang, Xiaotang Feng, Miao Yu, Weiwei Sha, Xiang Wang, Xiaobin Zhang, Xiangrong Zhang. Front Genet 2018
16
12

Activity-dependent shedding of the NMDA receptor glycine binding site by matrix metalloproteinase 3: a PUTATIVE mechanism of postsynaptic plasticity.
Thorsten Pauly, Miriam Ratliff, Eweline Pietrowski, Rainer Neugebauer, Andrea Schlicksupp, Joachim Kirsch, Jochen Kuhse. PLoS One 2008
38
12

Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia.
Yoon Seong Kim, Sung Soo Kim, Jeong Je Cho, Dong Hee Choi, Onyou Hwang, Dong Hoon Shin, Hong Sung Chun, M Flint Beal, Tong H Joh. J Neurosci 2005
201
12


Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors.
Sunyoung Lee, Shahla M Jilani, Ganka V Nikolova, Darren Carpizo, M Luisa Iruela-Arispe. J Cell Biol 2005
524
12

Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medication.
Nishantha Kumarasinghe, Natalie J Beveridge, Erin Gardiner, Rodney J Scott, Surangi Yasawardene, Antoinette Perera, Jayan Mendis, Kanishka Suriyakumara, Ulrich Schall, Paul A Tooney. Int J Neuropsychopharmacol 2013
45
12

Schizophrenia.
Kim T Mueser, Susan R McGurk. Lancet 2004
586
12

Myelin basic protein synthesis is regulated by small non-coding RNA 715.
Nina M Bauer, Christina Moos, Jack van Horssen, Maarten Witte, Paul van der Valk, Benjamin Altenhein, Heiko J Luhmann, Robin White. EMBO Rep 2012
25
12

Do schizophrenia and bipolar disorders share a common disease susceptibility variant at the MMP3 gene?
Cem Ismail Kucukali, Makbule Aydin, Elif Ozkok, Emine Bilge, Nurcan Orhan, Asli Zengin, Ihsan Kara. Prog Neuropsychopharmacol Biol Psychiatry 2009
9
12

Recent advances in understanding schizophrenia.
Chiara S Haller, Jaya L Padmanabhan, Paulo Lizano, John Torous, Matcheri Keshavan. F1000Prime Rep 2014
32
12

MMPs: a novel drug target for schizophrenia.
Kanwaljit Chopra, Ankita Baveja, Anurag Kuhad. Expert Opin Ther Targets 2015
21
12

Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine.
Hidenaga Yamamori, Ryota Hashimoto, Tamaki Ishima, Fukuko Kishi, Yuka Yasuda, Kazutaka Ohi, Michiko Fujimoto, Satomi Umeda-Yano, Akira Ito, Kenji Hashimoto,[...]. Neurosci Lett 2013
73
12

Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia.
H Häfner, W Löffler, K Maurer, M Hambrecht, W an der Heiden. Acta Psychiatr Scand 1999
283
12

Matrix metalloproteinase-3 in brain physiology and neurodegeneration.
Anna Maria Lech, Grzegorz Wiera, Jerzy Władysław Mozrzymas. Adv Clin Exp Med 2019
8
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.